Freenome Launches Multi-Cancer Detection Study Pairing Multiomics with Real-World Data
HIT Consultant
SEPTEMBER 12, 2022
Freenome is a biotechnology company with a comprehensive multiomics platform for the early detection of cancer using a standard blood draw. will help LHN members bring innovative cancer prevention testing to the communities they serve. A Comprehensive Multiomics Platform for the Early Detection of Cancer. Trial participation?will
Let's personalize your content